Lars C Steggink

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Top Venues

The pharmacogenomics journal

British journal of cancer

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Annemiek van Ommen-Nijhof, Judy N Jacobse, Lars C Steggink, Joop D Lefrandt, Jourik A Gietema, Flora E van Leeuwen, Michael Schaapveld, Gabe S Sonke
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors. Breast cancer research and treatment 196 (3) (2022)
Lars C Steggink, Hink Boer, Coby Meijer, Joop D Lefrandt, Leon W M M Terstappen, Rudolf S N Fehrmann, Jourik A Gietema
Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy. The pharmacogenomics journal 21 (2) (2020)
Johannes Stelwagen, Sjoukje Lubberts, Lars C Steggink, Gerrie Steursma, Lara M Kruyt, Jan Willem Donkerbroek, Arie M van Roon, Anne I van Gessel, Saskia C van de Zande, Coby Meijer, Christine H Gräfin Zu Eulenburg, Sjoukje F Oosting, Janine Nuver, Annemiek M E Walenkamp, Igle Jan de Jong, Joop D Lefrandt, Jourik A Gietema
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy. British journal of cancer 123 (11) (2020)